Understanding how small RNAs protect the genome from foreign threats
piRNA-mediated genome surveillance of germline transcripts
This study is looking at how tiny molecules called piRNAs help protect the DNA of tiny worms from harmful invaders like viruses and jumping genes, and it aims to understand how these molecules tell the difference between the worm's own DNA and the foreign stuff, while making sure important genes stay active.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10557913 on NIH RePORTER |
What this research studies
This research investigates the role of small RNAs, specifically piRNAs, in protecting the genome from invasive foreign nucleic acids like transposons and viruses. By using the model organism C. elegans, the research aims to uncover how these small RNAs distinguish between the organism's own genetic material and foreign elements, as well as how they silence these foreign threats epigenetically across generations. The study focuses on the mechanisms of gene licensing that prevent the silencing of essential genes while allowing for the defense against harmful nucleic acids.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to cancers or infertility linked to genomic instability.
Not a fit: Patients with conditions unrelated to genomic instability or those not affected by foreign nucleic acids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing genome instability and diseases such as cancer and infertility.
How similar studies have performed: Other research has shown success in understanding small RNA mechanisms in genome defense, indicating that this approach is promising and builds on established findings.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Lee, Heng-Chi — University of Chicago
- Study coordinator: Lee, Heng-Chi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.